Isoflavone-containing composition
US7939060B2 · kind B2 · utility
5Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2008 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Jul 5, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.